Scarica l'app Stockscreener
3.2429
1.84%
-0.0771
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SGHT Giù?
Forum
Previsione
Precedente Chiudi:
$3.32
Aprire:
$3.25
Volume 24 ore:
85,889
Relative Volume:
0.40
Capitalizzazione di mercato:
$167.32M
Reddito:
$81.06M
Utile/perdita netta:
$-55.55M
Rapporto P/E:
-2.8446
EPS:
-1.14
Flusso di cassa netto:
$-47.98M
1 W Prestazione:
-6.62%
1M Prestazione:
-16.65%
6M Prestazione:
-47.01%
1 anno Prestazione:
-36.96%
Intervallo 1D:
$3.16
$3.26
Intervallo di 1 settimana:
$3.16
$3.52
Portata 52W:
$3.16
$8.45
Sight Sciences Inc Stock (SGHT) Company Profile
Nome
Sight Sciences Inc
Settore
Industria
Telefono
(415) 889-0550
Indirizzo
4040 CAMPBELL AVE,, MENLO PARK
Confronta SGHT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
3.25 | 167.32M | 81.06M | -55.55M | -47.98M | -1.14 |
|
ABT
Abbott Laboratories
|
112.86 | 196.55B | 41.22B | 5.77B | 6.49B | 3.29 |
|
BSX
Boston Scientific Corp
|
95.73 | 141.03B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
366.83 | 138.80B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
81.57 | 106.02B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
73.36 | 43.73B | 6.60B | 4.16B | 490.10M | 6.93 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-06 | Iniziato | UBS | Buy |
| 2024-11-04 | Downgrade | Lake Street | Buy → Hold |
| 2024-08-21 | Iniziato | Lake Street | Buy |
| 2023-09-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-09-12 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | Downgrade | Citigroup | Buy → Neutral |
| 2023-01-06 | Aggiornamento | Stifel | Hold → Buy |
| 2022-10-04 | Iniziato | Needham | Hold |
| 2022-07-26 | Iniziato | Stifel | Hold |
| 2022-02-03 | Iniziato | William Blair | Outperform |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
Mostra tutto
Sight Sciences Inc Borsa (SGHT) Ultime notizie
Sight sciences CTO David Badawi sells shares worth $12,478 By Investing.com - Investing.com Australia
Insider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CTO Sells 3,829 Shares of Stock - MarketBeat
Sight sciences CTO David Badawi sells shares worth $12,478 - Investing.com
Sight sciences chief legal officer Jeremy Hayden sells $5,898 in stock - Investing.com
OMNI Surgical System shows promise in glaucoma care By Investing.com - Investing.com South Africa
Sight Sciences stock hits 52-week low at $3.29 amid market challenges - Investing.com Canada
OMNI Surgical System shows promise in glaucoma care - Investing.com India
Sight Sciences Announces Real-World 36-Month Study Confirming Long-Term Effectiveness of Standalone OMNI Surgical System in Managing Primary Open-Angle Glaucoma - The Manila Times
Sight Sciences Announces Real-World 36-Month Study - GlobeNewswire
Sight Sciences (SGHT) Announces Real-World 36-Month Study Confirming Long-Term Effectiveness of Standalone OMNI Surgical System - StreetInsider.com
Sight Sciences' OMNI System Shows Breakthrough 3-Year Success in Landmark Glaucoma Study - StockTitan
Sight Sciences CTO David Badawi sells $10,956 in stock By Investing.com - Investing.com Nigeria
Sight sciences CEO Paul Badawi sells $44,012 in stock - Investing.com India
Sight sciences chief legal officer sells shares worth $17,131 - Investing.com India
Sight sciences chief legal officer sells shares worth $17,131 By Investing.com - Investing.com Nigeria
Sight sciences CFO Alison Bauerlein sells shares worth $35,579 By Investing.com - Investing.com Nigeria
Sight sciences CEO Paul Badawi sells $44,012 in stock By Investing.com - Investing.com South Africa
Insider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CEO Sells 12,236 Shares of Stock - MarketBeat
Insider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CTO Sells 3,111 Shares of Stock - MarketBeat
Sight sciences CFO Alison Bauerlein sells shares worth $35,579 - Investing.com India
Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells $17,121.28 in Stock - MarketBeat
Sight Sciences CTO David Badawi sells $10,956 in stock - Investing.com India
Geode Capital Management LLC Raises Position in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Barclays PLC Increases Stock Holdings in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Receives $5.12 Consensus Target Price from Brokerages - MarketBeat
State Street Corp Increases Stock Position in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Given Average Rating of “Hold” by Brokerages - Defense World
Sight Sciences Announces the Results of a Budget Impact - GlobeNewswire
Sight Sciences' TearCare System Shows Major Cost Savings Over Traditional Dry Eye Treatments in New Study - StockTitan
Citigroup Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World
Sight Sciences secures $5 million in additional loan funding - Investing.com
Sight Sciences secures $5 million in additional loan funding By Investing.com - Investing.com UK
Where Sight Sciences Stands With Analysts - Benzinga
Sight sciences EVP Manohar Raheja acquires $19,250 in stock - Investing.com
Sight sciences EVP Manohar Raheja acquires $19,250 in stock By Investing.com - Investing.com UK
Sight Sciences (NASDAQ:SGHT) Research Coverage Started at UBS Group - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Sight Sciences (NASDAQ:SGHT) Coverage Initiated at UBS Group - MarketBeat
Sight Sciences initiated with a Buy at UBS - Yahoo Finance
UBS Initiates Coverage of Sight Sciences (SGHT) with Buy Recommendation - Nasdaq
UBS starts Sight Sciences stock coverage, forecasts strong sales growth by 2026 - Investing.com
UBS Starts Sight Sciences Inc. (SGHT) at Buy - StreetInsider.com
Sight sciences EVP Manohar Raheja buys $13,132 in stock By Investing.com - Investing.com Canada
Sight sciences EVP Manohar Raheja buys $13,132 in stock - Investing.com
Sight sciences EVP Manohar Raheja acquires $18,440 in stock By Investing.com - Investing.com Canada
Sight sciences EVP Manohar Raheja acquires $18,440 in stock - Investing.com
Millrace Asset Group Inc. Makes New Investment in Sight Sciences, Inc. (NASDAQ:SGHT) - MarketBeat
GSA Capital Partners LLP Invests $136,000 in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Nano Dimension Leads 3 US Penny Stocks To Consider - Simply Wall St
Independent Chairman Of Sight Sciences Sold 25% Of Their Shares - Simply Wall St
Sight Sciences Inc Azioni (SGHT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Sight Sciences Inc Azioni (SGHT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Badawi David | Chief Technology Officer |
Jan 08 '25 |
Sale |
3.26 |
3,829 |
12,479 |
1,749,541 |
3.22%
0.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):